Burning Rock Biotech Ltd reports results for the quarter ended in September - Earnings Summary

Burning Rock Biotech

16/11/2022 14:31

* Burning Rock Biotech Ltd  BNR.OQ  reported a quarterly
adjusted
loss of CNY2.23​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of CNY2.35 per share.
    * Revenue rose 22.1% to CNY154.63 million from a year ago;
analysts expected CNY153.50 million. 
    * Burning Rock Biotech Ltd's reported EPS for the quarter
was a
loss of CNY2.23​.
    * The mean earnings estimate of analysts had risen by
about 2.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Burning Rock Biotech Ltd shares had fallen by 4.6% this
quarter and lost 76.1% so far this year.
    * The company reported a quarterly loss of CNY231.48
million.
    * Wall Street's median 12-month price target for Burning
Rock
Biotech Ltd is $6.70 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
16 at 02:31 p.m.  ​All figures in Chinese yuan renminbi unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -2.35          -2.23          Beat
 Jun. 30 2022      -2.40          -2.50          Missed
 Mar. 31 2022      -2.41          -2.50          Missed
 Dec. 31 2021      -1.69          -2.40          Missed